NDC 61958-3001 – Sunlenca
Lenacapavir Sodium 300 mg/1 · Tablet, Film Coated · Oral
Product NDC61958-3001
Product details
- Brand name
- Sunlenca
- Generic name
- Lenacapavir Sodium
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA215974
- Marketed since
- December 22, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Human Immunodeficiency Virus 1 Capsid Inhibitor
Active ingredients
- Lenacapavir Sodium 300 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 61958-3001-1 | 1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK | Dec 22, 2022 |
| 61958-3001-2 | 1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK | Dec 22, 2022 |
| 61958-3001-3 | 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3) | Nov 13, 2024 |
Other Sunlenca products
- 61958-3002 · Kit · Gilead Sciences, Inc.
- 61958-3005 · Kit · Gilead Sciences, Inc.